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Foreword 
It is reported that more than 1,500 plant species with medicinal properties have been used in 
Pakistan. Local practitioners of Unani and Folk medicine are reported to be regularly using at least 
30 species for the treatment of common ailments. There is a great potential in effectively utilizing 
these valuable plant resources to improve the primary health care system of the rural communities, 
especially in the northern mountain regions of the country. Similarly, there are opportunities for 
rural and tribal peoples to harness the economic potential of these plants through a sustainable 
system of utilization. 
This report provides an overview of the medicinal plants sector in Pakistan and identifies 
major issues, focussing on priority areas for research and development. The conservation and 
development activities in medicinal plants are currently facing a number of constraints such as 
lack of information database and exchange, coordination & collaboration and R&D fund. A holistic 
approach of study, research and development is required. 
The report suggests that further studies are needed to gain an in-depth understanding of the 
social and institutional context of the market, needs and interests of the key stakeholders and 
development of a centralized system of information base. It also recommends stronger national 
coordination and collaboration among different agencies from both formal and non-formal sectors 
with participation of the private sector where possible. 
We hope that the actions and interventions suggested in the report will facilitate the development 
of a sustainable and viable medicinal plants sector in Pakistan. 
Roger Finan Madhav Karki 
Regional Director Regional Program Coordinator 
South Asia Regional Office (SARO) Medicinal & Aromatic Plants 
IDRC, New Delhi Program in Asia (MAPPA) 
!DRC/SARO, New Delhi 
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This report reviews the current status of the medicinal plants sector in Pakistan, focusing on 
priority areas for research and devebpment. It reveals the existence of a strong classical traditional 
medicine sector, based predominantly on the Unani system of medicine, which dates back to the 
lndus valley civilization. This traditional medicine sector provides an important source of 
employment, though as yet unquantified, and health care, especially in rural and tribal areas of the 
country. 
Long standing research on medicinal plants in Pakistan also points to a rich resource base, 
spread over a wide range of ecological zones, with estimates of numbers of plant species with 
medicinal properties varying from 3,200 species at the upper end of the spectrum to 1,000 at the 
lower end. Of these species, approximately 500 are known for their active constituents from research 
conducted in Pakistan and elsewhere, and around 250 to 300 species are known to have entered 
the herbal markets of Pakistan. 
However, despite the strengths and opportunities for the development of the medicinal plants 
sector described above, it is clear that Pakistan's comparative advantage in producing materials 
for export, as well as for the domestic market, has not been fully exploited. This is largely due to 
the fact that at present, there is no clearly definable medicinal plants sector, resulting in the absence 
of a coordinated approach as well as of clear, result-oriented policies affecting the sector. Such 
policies relate to areas including regulations and trade practices, the promotion of innovative 
conservation measures and the sustainable utilization of medicinal plants. 
Constraints exist at all levels of the sector. These are discussed in the report and include a 
fragmented information base; an uncoordinated approach to collection and marketing of medicinal 
plants; export constraints; training and educational constraints; institutional and funding constraints, 
and lack of prioritization with regard to species. 
What is clearly required is an in depth understanding of the social context of the market, and 
the contributions, interests and roles of the key stakeholders involved in the medicinal plants sector. 
These include the central government and its research organizations; provincial governments and 
their extensions; the private sector dealing with Unani medicine and the practice of traditional 
medicine, and the collectors, that is, rural and tribal communities. If this base is broadened to 
include international and regional information networks, on one hand, and relevant non-governmental 
organizations involved with the collectors and users of medicinal plants on the other, new and 
effective partnerships could emerge. These would make an invaluable contribution towards achieving 
the goals of poverty alleviation, environmental and biodiversity conservation and rationalization 
and an increased share of international trade in raw materials relating to medicinal plants, which 
would require the implementation of government policies and incentives. 
(ix) 
Priorities for Medicinal Plants Research and Development in Pakistan rt 
The Government of Pakistan has in place a number of organizations and initiatives aimed at 
strengthening and coordinating various aspects of the sector, supplemented by non-government 
and private sector initiatives. However, stronger coordination of the sector at the national level is 
not by itself sufficient unless appropriate multidisciplinary strategic action has already been taken 
at the research and development level. 
This report outlines a number of such actions and interventions, which would greatly facilitate 
progress towards establishing a viable and sustainable medicinat plants sector in Pakistan. 
(x) 
Priorities 
for Medicinal Plants 




Health Systems and the 
Resource Base 
Chapter 1 
Cultural Background, Health Systems and the Resource Base 
Iii, . . . . ., ,. . i t.'j ... I. 
Although modern day Pakistan contains the major archaeological sites of the lndus civilization, 
originating from around 4500 BC, the cultural fabric of the country owes much to two events. 
Firstly, the period of Aryan invasions between 4000 and 3500 BC not only created ethnic 
transformations, but also links to the civilizations of Mesopotamia, Egypt and Greece. Further, 
international trade relations began to emerge during this period between the region and China, 
India and the Mediterranean. Secondly, the Muslim conquest of the Indian subcontinent, 
commencing from 1221 AD, led to divergences in religions and cultures, which continued to co- 
exist until partition. 
The traditional Indian system of medicine, known as Ayurveda, which evolved during the period 
commencing from around 2500 BC, had been codified and documented by 600 BC. Ayurveda 
came to be associated with the Hindu peoples, while the Muslim peoples of the subcontinent 
adopted a different traditional system known as Unani. Unani traces its origins to Greek medicine, 
which was adopted by the Arabs and thereafter spread to both Europe as well as to India. It had 
already been enriched by contacts with Chinese and Indian medicine, and with its major spread in 
India under the Muslim rulers, it became incorporated within the Ayurvedic system. In fact both 
systems, Ayurveda and Unani, benefited from and complemented each other (Bala, 1982). 
The roots of the Unani system go back to the materia medica of numerous early civilizations, 
many of which are documented. These include the Ebers Papyrus of Egypt (1500 BC) which 
contains a list of drugs, mostly plant-based; Assyrian. and Babylonian pharmacy tablets dating 
from 650 BC listing 250 herbs; writings of Greeks such as Theophrastus, Pliny the Elder and 
Galen, and many Arab texts including Avicenna (written by Sheikh Bu Ali Sina, the father of modern 
Unani), and texts by lbu al-Baitar (1197-1241 AD). The latter travelled widely through the 
Mediterranean and Southwest Asia and consolidated many earlier texts, producing a list of 2000 
drugs of which 1700 were herb-based (see Hamdard, 1969 for a detailed treatment of this subject). 
Western or allopathic medicine was introduced to British India, primarily in order to combat 
epidemic diseases. However, traditional medicinal systems continued to co-exist for many decades, 
and after the independence of Pakistan they remained the major system of health care, especially 
in rural areas. Although the government of Pakistan has actively promoted allopathic medicine it 
has come to the realization that the traditional systems also have a key role to play, particularly 
with regard to primary health care. 
The dominant traditional system of medicine in Pakistan is the Unani system. This report will 
therefore focus primarily on this subject. However, it should be noted that there are also numerous 
and diverse uses of plants as home remedies. Homeopathy is becoming increasingly recognized 
and accepted as a system of health care. In a few northern areas, Amchies and Sanyasis (as 
opposed to the Hakims practising Unani) are the hereditary practitioners of somewhat secret 
medicinal systems which are basically Ayurvedic in nature. Interestingly, tribal peoples in Pakistan 
do not appear as in India to have developed major systems of medicine, utilizing instead the Unani 
system of medicine (Cherla and Holley, 1997). However, they have contributed a valuable knowledge 
base of local plants, though the efficacy of these has not yet been scientifically studied. 
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ti The Plant Resource Base 
Although the complete flora of Pakistan is not yet known, it is estimated that there are about 6000 
species of higher plants (Stewart, 1972). Estimates of numbers of medicinal plant species vary 
greatly from 3200 species at the higher end of the spectrum (FAO, 1987) to 1000 at the lower end. 
(Ahmad, 1996). In part this reflects historical work conducted on flora which has basically focussed 
on taxonomy, with descriptions and plant uses frequently not being stated This was the case 
during the period from 1947 to the mid I 960s during which reports on detailed medicinal usages 
were incomplete and random Accumulation of data on medicinal plant usages only began with the 
implementation of more intensive surveys, conducted on the basis of provinces. 
The detailed surveys were conducted under the auspices of several authorities. Examples 
include surveys carried out in Sind by the Pakistan Agricultural Research Council (PARC), in 
Baluchistan by the Pakistan Science Foundation (PSF) and in Azad Kashmir by the Pakistan 
Association for the Advancement of Science. Check lists and references still widely used include 
those produced by the Pakistan Forest Research Institute (1965). Notable institutions involved in 
the design and implementation of the surveys include the National Herbarium of PARC which has 
responsibility for the flora of Pakistan, as well as some of the universities in Pakistan. In response 
to conservation interests, surveys focusing on specific localities as opposed to widespread surveys, 
have accelerated in very recent years. An example of such a survey is that of Zaidi (1997). 
A number of the more recently conducted studies and surveys stem from the realization that 
floristic studies alone are inadequate and that considerably more ethnobotanical knowledge is 
required. This is all the more apparent due to the fact that the hakims or traditional practitioners of 
Unani are primarily concerned with the supply of medicinal plants as opposed to their occurrence 
and distribution in various regions or ecological zones. (Shinwari, 1996). 
Data is not therefore readily available on which species require conservation; their locations, 
and which species require the use of alternative strategies to reduce over exploitation 
t2 The Medidnal Plants Supply 
There are no coordinated methods in use for the collection and sale of medicinal plants 
Requirements for specific plants or plant parts are broadcast by wholesalers, using local names to 
the collectors, who are traditionally nomadic tribes who graze their animals in the mountains 
during the summer and in the plains during the winter. Collection of medicinal plants provides an 
additional source of income for the collectors who appear to be predominantly women according 
to a study carried out in Chitral (Khan et al. 1996). 
The dealers are unconcerned about the fact that collectors are untrained with regard to 
harvesting procedures. This is manifested in increasing tendencies to over-collect on a totally 
unsustainable basis, and ignorance of the need for seasonal collection of particular materials. In 
addition adulteration in order to increase bulk is exceedingly common 
The increasing shortage of medicinal plant supplies was highlighted during a national conference 
organised by the National Institute of Health, Islamabad in 1991, as well as during a national training 
workshop on Ethnobotany organised by PARC (National Herbarium), WWF and ICIMOD in 1996. 
The causes for this were variously attributed to over collecting, over grazing, and cutting of trees 
for fuelwood, as well as over population in some areas. 
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Although statistics on the degree of endangerment of species across different provinces, ecologies 
and climates do not exist, it is clear that medicinal plants come from a wide range of localities. 
A total of over 700 species of the flora of Pakistan are reported to be endangered (Chaudhri and 
Qureshi 1991). 
Despite the lack of statistics, there is overwhelming agreement among experts in the country 
that the most threatened ecosystems are temperate forests in the upland areas. One example 
taken from the Swat region vividly illustrates this as seen in Table 1. Malik et aL (1990) also 
highlight the rapid loss of arid forest ecosystems in protected areas in Baluchistan. The other 
ecosystems under threat with regard to medicinal plants are desert areas. 
Table 1. Medicinal Plants in the Forest Ecosystems of Swat (250-3900m) 
Total number of medicinal species 350 
Number endangered 5 
Number threatened 16 
Number vulnerable 18 
Number rare 10 
(Data from Ahmad and Sirajuddin 1996) 
Of the actual species under varying degrees of threat, only 30 percent are included in the 
Pharmacopoeia. This highlights the point that many species according to ethnobotanic surveys 
are in fact used, but their efficacy has never been scientifically tested. 
13 Collections of Medicinal Plants 
The Unani-based system in Pakistan did not actively promote the establishment of a series of 
medicinal plant gardens to provide supplies of raw materials for herbal drugs. Instead there has 
been virtually complete dependence on collection from the wild for local use, consumption by drug 
companies and even for export purposes. 
A number of plantations exist but these are related to research interests and are far from 
comprehensive. For example, collections exist at the Forest Research Institute, Peshawar and at 
the Pakistan Council of Scientific and Industrial Research (PCSIR) Laboratories, Peshawar. In 
addition, some plantations are associated with teaching institutions—universities as well as hakim 
training centres. 
Nonetheless, these are all far from comprehensive and amount to little more than specimen 
collections. Further, they are not well maintained since they have depended on the duration of 
particular research projects, and all of the collections suffer from lack of funding. In addition, the 
concept of genetic variation patterns within species' gene pools has hardly been appreciated. For 
instance, under an externally-funded project, the Forest Research Institute studied the need to 
regenerate some important indigenous and exotic medicinal plants in the wild forests of the North 
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West Frontier Province during the period from 1985 to 1991. Twelve species were involved of 
which one was tested using three provenances; one using two provenances and the remaining ten 
using a single provenance (Kalim, al. 1992). Studies conducted in most institutions, involving 
phytochemical analysis, also tend to rely on single provenances. 
Yet it is widely known that in the wild, populations existing in particular ecological systems 
may have diverse contents of active principles. An eco-geographical approach is needed with 
regard to sampling for research; for maintenance of materials in collections; for evaluation and use 
and for conservation. 
t4 Conservation of the Resource Base 
Pakistan has established reserve areas, mainly national parks, covering 10% of the total land 
area. However, due to the fact that management and resources available for these areas are very 
limited, over exploitation of medicinal plants continues. Recent funds granted to the Government 
by the Global Environment Facility are enabling IUCN Pakistan and the Forest Research Institute 
to jointly develop management plans, initially for a very limited number of areas. Consequently 
much more remains to be done. 
In a few cases involving hill forests in the Northern areas, agreements are being made, through 
the provincial forest departments, and community groups, to declare the areas as protected, 
whereby no extraction of medicinal plants is to be permitted for a period of 6 years. Consequently 
some degree of regeneration should occur. 
In this regard, it is clear that resource tenure rights have to be clarified and that management 
of resources by local communities and NGOs should be fufly incorporated into management plans 
and strategies for medicinal plants supply. 
In sum, it is apparent that exsituconservation of the medicinal plants resource base does not 
exist, and that in situ conservation is not yet effective. 
t5 Understanding the Wider Resource Base 
Many of the medicinal plants indigenous to Pakistan are also distributed in other countries, 
where research is ongoing. Pakistani scientists have much to gain by exposure to the wider 
literature available, for example, on methodologies for evolving commercial varieties of Plantago 
ovata, Papa ver somniferum, Rauwo/fia serpent/na, Rosa damascena, Vet/veria zLzanio/des, 
Hyoscymus niger several Menthasp., several Ocimumsp., and other species in India. In Nepal, 
plants for the extraction of essential oils involving value addition to the materials have been established 
at the village level. Tissue culture for propagation has been developed in various Iaboratoris, 
some with direct relevance to Pakistan. 
However, the most strategic need will be for Pakistan to develop research techniques for the 
evaluation of priority species gene pools so that the best materials can be used in adapting techniques 
developed elsewhere, or in devising new local techniques for the utilisation of the resource base, 
while at the same time aiding its conservation. In this respect, tissue culture for conservation and 
utilisation has been well researched elsewhere with regard to important medicinal plant species 
such as A con/turn heterophyllum, Nardostachys jatamans/ Orch/s /atifo//a, PicrorrhLza kurroa 







No economic analysis exists to date for the marketing chain from collection to consumption 
systems. All available data relate to quantities traded in markets at a specific time and their 
approximate values. Table 2 itemizes availability and quantities of medicinal plants, based on old 
data. However, the relative proportions have remained almost constant. 
Table 2 Medicinal Plants Availability and Quantities 
(annual consumption 1978, . = sizable quantities available during the mid-i 980s) 
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Plant Vernacular Annual Indigenous or 
Name Consumption Imported 
(00 kg) 
Asparagus Mush Sufaid 74 India 
adscendens 185 N, P 
A. offic/nal/s Hahiyun 222 Pakistan 
A. raceniosus Satawar 55.5 India 
a Serberis lycium Sunblu, Sumlu 37 B,K,N,P 
• B. vulgar/s Zarishk Shirin 37 B,K,N 
Bonibax nia/abaitcuni SimbaI 37 India 
• Brass/ca juncea Rali 74 PS 
a Buxus papilosa Shamshad - Mahakand and 
Hazara 
Coccinia glauca Gaazaban 370 Iran 
• Calotrop/sprocera Aska 18.5 BJP,S 
a C. giqantea Aska B, P,S 
Ca#hamnus Tukhamigartum P 
t/nctorius 
Carum carv/ Zira Sufaid 740 Pakistan/Iran 
a C. bu/bocastorum Zira Siah N 
C. capt/cu/n Ajwan 740 P,S 
370 India 
* Cassia absus Chaksu 185 P (Plantations) 
C. arigustifol/a Sennatiindi 370 S/India 
* C. ftstu/a Amaltas 370 P,S 
a C. abovata Kasordhi - P,S 
Celastrus Malkangni 74 IndialPakistan 
pan/culata 
Centaurea behen Behman surkh 74 
Behman uf aid 111 
10 
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• ommiohora mukul 
Cord/a dichotorna 





• Delphinium denuda turn 




• Ephedra gerardiana 
• E. rebrade/s 
Euphorbia resinifera 
Fagonia cretica 
• Ferula foetida 
Ficus car/ca 
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[int Vernacular Annual Indigenous or 
Name Consumption Imported 
(00 kg) 
G/ycyrrh/za Malathi 1036 China 
glabra (Extract only) 
Greuria asiatica Phalsa - P,S 
Ho/arthena Indirjo - india 
ant/dys enter/ca 
Hygrophi/aspinosa Talmikhana 74 India 
Hyoscyarnus n/ger Ajwan-e-Khurasanni 185 B,KN 
11//c/urn an/saturn Bakiankhatai 111 China 
I. grifithhl Saunta 740 Pakistan 
Lallemantia Tukhamibalangh - P,S 
rayleana 
Lamprac/iaenium Brahmi dandi 37 Pakistan 
microcephaluni 
Lavendula stoechas lJstukhudus 414 Bahrain 
Lawson/a a/ba Hena - P,S 
a Lep/dium sativum Halon - P 
Linurn AIsi 148 Cultivated 
usitafiss/niurn 
Lochnerarosea Ratanjot 185 Pakistan 
Lycopus europaeus Jutnim 37 K 
• Ma/lotus Kamila 37 K,N,S 
phiIipinens/s 
a Ma/va sy/vestris Tukhami-khubazi - P 
Matricaria chaniom///a Babuna 37 B, P 
(Ant/iernid/s floris) 
Melia azadirachta Tukhm Bakain 18.5 B,P 
Me/ia azedracti Mm As much as possible N,P,S 




Plant Vernacular Annual Indigenous or 
Name Consumption Imported 
(00 kg) 
Mimosa pud/ca Lajwanti 37 India/Bangladesh 
MarL/s a/ba Shehtoot 37 Cultivated 
Myris'tica fragrans Jaiful 148 India/Pakistan 
Myrtus commun/s Habul-Aas 148 B,K,N, also 
cultivated 
Ne/umb/um speciosum Kauldode 185 Pakistan 
•Nepetarudera//s Badrangboya 37 B 
Nie//a sat/va Kalonji 
. 111 P 
Nymphaea a/ba GuI Nilofar 222 P,S 
Oc/mum basil/cum Takhan-e-fang mushk B,S (cultivated) 
O.p/Iosu,n Tukhan-e-rehan - N 
Onasina ech/oldes Ratanjot 185 N 
Peganum henna/a H ermal - B,S 
• Peucedanuin Sowa 370 8,P 
graveo/ens 
Pi;oercubeba Kababchini 37 Singapore 
Pistacia /ntegemmtna Kakar Singhi 74 N,P 
• P/antagoinajor Bartung 111 China/India 
(but also in B,P) 
• P ovata Isabaghol 740 B,P,S 
Po/ygonuin Anjbar 370 India 
v/viarum 
• Pongamia g/abra Karanjawa - S 
Psoralea cory//folia Babchi Large quantity India 
• Pun/ca granatum Anar-dana - Cultivated in 
B,N,P 
Quercus infector/a Maju 148 Iran 
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• Rhazya stricta 
a Rheuni ernodi 
• Rho dodendron 
cainpanu/atum 
• Ric/nus cominunis 
a Rosa damascena 
• I?. inoschata 
Rumex tnarit/nws 
Salviaplebela 
a Sa/vatora pers/ca 
Sap/n dus 
triloliatus 
• S. mukrossi 
• Saussurea lappa 
Semecarpus 
anacardium 
• Sesamum indicum 

































As much as 
possible 


































Plant Vernacular Annual Indigenous or 
Name Consumption Imported 
(00 kg) 
Economic Background 
Plant Vernacular Annual Indigenous or 
Name Consumption Imported 
(00 kg) 
Thymus sorpyllum Ban-ajwain - B,N 
Va/er/ana hard wick/i Bekh Kabir - Pakistan 
Valer/ana Mushkbala - K,N,P 
wall/c/ui 
• Viola odorafa Banafsha 370 K,N,P 
• V serpens Banafsha - K,P 
V/t/s vin/fera Munaqqa 740 Pakistan 
• Withan/acoagulens Painrdodi - B,S 
• W somnifera Asgan - India (also in 
B,N,P,S) 
Zanthozy/um alatum Tim mer 3700 N, P 
Z1z4hus sat/va Unab 370 Iran/Afghanistan 
(also in B,K,N,P) 
1) Data from lkram and Fazal 1978, and from manuscripts available at PCSIR, and PFI, Peshawar. 
2) B= Baluchistan, K= Kashmir, N= NWFP (North West Frontier Province), P= Punjab, S= Sind 
Of considerable concern is the fact that many of the species listed in Table 2 with an asterisk 
attached to their names were plentiful in the 1 980s but are now rare or becoming extinct, irrespective 
of habitat. These include D/oscorea deltoides from exposed habitats, and Podophyllum emod/ 
from coniferous forests. 
The origins of species is of great interest because large quantities of individual medicinal 
plants come from Afghanistan, for example Coichicum luteum, Ferula foet/da and GlycyrrhLza 
glabra. All three species are also indigenous to Pakistan but local supplies are inadequate or 
unavailed of by traders. Other plants are imported from India, Sri Lanka, China, Bahrain, Iran, 
Yemen, Morocco, Tanzania and Spain. The amounts imported are not clear, with the exception of 
species which are not found at all in Pakistan. Much of the importing is across borders and takes 
place in the informal sector. 
In some cases, the imports are long-standing and traditional. Scientific knowledge has never 
been applied with regard to substituting local species for imports. Thus, for instance, Paeon/a 
off/c/na/, is still imported despite the fact that P emod/ which is a good substitute, is locally 
available and has the same medicinal properties (Qureshi and Ahmad, 1996). 
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21 Herbal Markets 
Most traders are reluctant to disclose volumes of trade for fear that information will be passed 
on to the tax authorities (Khan, 1985). However, it is known that trade in herbal materials is 
monopolised by wholesale drug dealers in most of the markets, with the remaining shopkeepers 
and dispensers relying on the wholesalers for their supplies (Appendix 1). 
A survey of the drug markets carried out by the Pakistan Forest Institute in Peshawar gathered 
information on 250 plants and their volumes traded. Consumption of some imported medicinal 
plants in Pansarmarkets (Peshawar and Mardan in NWFP; Rawalpindi, Lahore, Faisalabad, Multan 
and Bhawalpur in Punjab; Hyderabad and Karachi in Sind) are shown in Tables 3, 4, 5 and 6. 
In addition to the species shown in the tables, the following could be added to illustrate the 
dependence on imports - to Table 3: Zizyphus vulgar/strom Afghanistan; to Table 4: Term/na//a 
chebula from India; to Table 6: Prunus cydonia from Spain, Rub/a Cord/folla from Iran, A/pin/a 
ga/angafrom India and Bangladesh, Pimp/ne//a an/sumfrom Iran, Nepetarudera//sand Lavendula 
stoechas, both from Iraq and Iran, Plumbago Zey/anica from China, Cuscuta reflexa from India 
and Hygrophila spinosa from Afghanistan. 
Table 3 Consumption of Crude Drugs in Pansar Markets of Pakistan 
A. More than 200 tons sold: 
rSpecies Local Part Quantity Approximate Source 
Name Used Consumed Value in 
t/annum 000 (Rs) 
G/ycyrrhlza Mulathi Roots 2506 16289 Major source of 
glabra supply is 
Afghanistan; 
material is sent to 
Karachi 
Carurn Ajwain Seeds 274 2466 Sindh, Swat & 
copt/cum Hazara 
Va/eriana Mushk-e- Roots 282 4760 Swat, Dir & 
walllchi Hazara. 
Pun/ca Anardana Seeds 349 593 Haripur & 
granatum Hazara are the 
main centres for 
collecting. 
Cuminum Zeera Fruits 267 3471 Baluchistan. 
cyminum saf aid 
Onosma Gaozaban Leaves 370 2960 Iran. 
bra cteatum 
Carum Kalazeera Fruits 297 14850 Chitral & Gilgit 
bulbocastanuni Agency. 
(Data from Khan 1991) 
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Table 4 Consumption of Crude Drugs in Pansar Markets of Pakistan 
B. 100-200 tons sold: 












825 Swat & 
7080 Hazara 
Adiantum Personshan Whole 
cap illus-veneris Plant 
175 1225 Swat, Hazara 
Dir, etc. 
Ferula Hing Gum 
foetida 
183 16470 Gilgit& 
Afghanistan. 
Polygonuni Anjabar Roots 
amplex/ca vie 
116 754 Swat, Hazara 
& Rawalpindi. 
Rheul,! emodi Revand Roots 
Chini 
126 630 Swat, Hazara 
& Peshawar. 
(Data from Khan 1991) 
Table 5 Consumption of Crude Drugs in Pansar M arkets of Pakistan 
C. Less than 100 tonnes sold: 








Arteni/sia Afsantine Twigs 
quettensi 







Sisymbrium Khakshir Seeds 
ir/o 
81 810 NWFP & 
Punjab. 
Cichorium Kasni Seeds 
fritybus & Roots 
53 795 Punjab. 
Saussurea Kuth - Roots 
lappa 
50 150 Azad 
Kashmir. 
(Data from Khan 1991) 
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Table 6 Consumption of Crude Drugs in Pansar Markets of Pakistan 
D. Less than 50 tons sold: 
Species Local Part Quantity Approximate Source 
Name Used Consumed value in 
t/annum 000(Rs) 
Swert/a Chirata Leaves 33 330 Swat & 
chirata Hazara 
8e,t, er/s Darhald Roots 43 744 Swat, Hazara 
lyc/uni & Dir. 
Hyoscyanius Khurasani Seeds 30 840 Pehawar& 
nier ajwain Quetta. 
Cente/la Barmi . Whole 9 135 Hazara, Swat 
asiat/ca booti Plant & India. 
Ocirnurn Tukhm-e- Seeds 2 120 Quetta & 
Basi//cuni frangmushk iran. 
Garthanius Tukham-e- Seeds 11 66 Punjab. 
t/nctorius gartum 
Aconitum Atis Corms 31 120 NWFP 
nape//us especially Swat 
& Hazara. 
(Data from Khan, 1991) 
2.2 Manufacturers 
There are about 15 major manufacturers (Dawakana) of drug preparations following the Uriani 
system. Drugs are made up according to Unani recipes, and packaged and sold through 
shopkeepers and dispensaries. 
The formulations may be complex as shown in Table 7 or relatively simple as shown in Table 8. 
Table 7 Formulation for Mufforeh Mo'fadil 
[plant ocaI Name 
Cuscuta reflexa aftimum 30g 
Aqullaria agaiocha agar lOg 
Nepetah/ndostana badranj boya 20g 
Pterocarpus santa//ntis burada sandal surkh 40g 
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Plant Local Name Quantity 
Santa/urn album burada sandal safaid 40g 
Onosma bre'teatum berg gaozaban 1 Og 
Banibusa arundinacea bang loch an 40g 
Papa ver somniferum tukhm khashkhash 20g 
Ocirnum basiicum tukhm franjmushk 20g 
Cichorium intybus tukhm hasni 25g 
Doronicum hookeri daranaj agrabi lOg 
Z/ngiberzerurnbet narhachur 20g 
Cinnamonurn cassia sazai Hindi 20g 
Cor/andrum sativiLim kishniz khushk 25g 
Armenian bole gilArmani 20g 
Viola oderata gulbanafshah 30g 
Rosa daniascena gul-i-surkh 30g 
Camphora officinarum hafur 5g 
Coral//urn rubruin bussud ahmar mahtul log 
Vateria fad/ca kahruba-i-shamai 25g 
Pearls, ground marwarid mahiul log 
Honey shehed 850g 
White sugar syrup gieram shakar safaid 850g 
Sodium benzoate nitrun bunjawi 3g 
Ambra grassea ambar lOg 
Musk mushk 600g 
Crocus sat/vus zof ran 5g 
Aqua Oiiosma bracteatum arg gaozaban 20m1 
Silver foil warag nugra log 
Dosage : 5g in the morning as a cardiac stimulantlcephalic tonic/anodyne antipalpitant/cure for 
melancholia. 
Source: Hamdard Pharmacopoeia 
Table 8 Formulation for Ma'jun Anjir 
Ptant Local name Quantity 
Termina/h chebula poast halila zard 1 25g 
/pornoea turpethum turbud safaid 50g 
Convo/vu/us scannionia saqmunia 50g 
Cassiaangustifo/ia sani-i-makki 50g 
Rosa damascena gul-i-surkh 50g 
Ficus carica anjir zard 50g 
Vitis vinifera mawaiz munaqqa 250g 
White sugar syrup giwam shakar safaid 
Dosage: lOg at night with milk for persistent constipation. 
Source : Hamdard Pharmacopoeta 
19 
Priorities for Medicinal Plants Research and Development in Pakistan 
2.3 Constraints and nterventions in Marketing and 
Manufacturing Herbal Drugs 
It is widely opined that a number of preparations available to hak/insand on sale in dispensaries 
are below standard and often do not work. There are several reasons for this: adulteration at the 
collecting level; non-availability and therefore omission of a particular ingredient from a preparation 
of which it forms a component; and poor storage (unhygienic, poor ventilation, infestation by 
microorganisms). Quality is therefore a vital consideration. 
In addition to preparation and sale of herbal formulations, some of the large companies are• 
well aware of the constraints involved and are trying to overcome them. A leading company in this 
field is Hamdard which has a Pharmaceutical Advisory Committee and which has established the 
prominent and widely known Unani Institute of Health and Tibbi Research in Karachi. It is headed 
by Hakim Mohammed Said. Another smaller company which manufactures remedies, Quirshi, 
also tries to maintain quality standards. 
The government is aware of the constraints but lacks the manpower to address them. The 
Ministry of Health through a programme on traditional medicine is keen to introduce traditional 
medicine for primary health care into villages but the situation is complex and the programme 
under-funded. 
The sheer scale of education and training required at the practitioners level can be appreciated 
when it is estimated that there are over 50,000 hakims, many of whom are poorly educated. 
Despite a lack of certain materials and adulteration, a few examples do illustrate the Ieveis of 
profit accruing along the chain. Qureshi and Ahmad (1996) cite the case of Viola oderata flowers. 
These are picked by the collectors, dried and transported to the wholesalers in the town. One 
kilogram is purchased for Rs. 150. The wholesalers then sell the product to retailers at the rate of 
As. 350/kg, and finally the retailers sell it at a rate of As. 5/1 Og (Rs. 500/kg). The collector is not 
always involved in this activity for the sole purpose of a cash return. In remote areas such as 
upland valleys, Zaidi (1996) notes that local people collect medicinal plants for home use with a 
certain amount being taken to the market to be exchanged for provisions rather than for cash sale. 
2.4 Exports of Medicinal Plants. 
In the last 1 5 years, Pakistan has exported limited quantities of medicinal plants. Table 9 lists 
nine important species. However the quantities described are outdated since they apply to 1978. 
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Name of Plant Part Used Total 
I 
Quantity In kg 
1. Acacia arab/ca Gum - 857,075 
2. Caruni copt/cum Fruits 9,900 
3. Gum/aiim cym/nuni Fruits 687,950 
4. Ephedra sp. Twigs 64,950 
5. Foen/cu/umvu/gare Fruits 316,650 
6. Papa ver somn/ferum Seeds 731 ,20& 
7. Rheutn etnodi Roots 143,000 
8. Ric/nus camrnunis Seeds 6,937,000 
9. Va/er/anawa///ch// Rhizomes . 346,320 
(Data from lkram and Hussain 1978) 
Of the species described above, Ephedra has been the most exploited and export is therefore 
restricted by the CITES Convention. Rheum emod/and Va/er/ana wa/llch//are also grossly over- 
collected. Other species erratically entering the exports arena are Lawson/a a/ba, G/ycyrrhiza 
glabra, Rosa damascena and P/antago ovata. Exports are made sporadically to Dubai, France, 
Germany, Hong Kong, Korea, India, Italy, Japan, Saudi Arabia, Singapore, Sri Lanka, Switzerland, 
UK and USA. and are largely channeUed through the Karachi market. Around ten companies are 
involved with the export of medicinal plants (Menon and Shahani, 1988). 
Constraints Related to Exports 
Export of herbal products from Pakistan is constrained by quality considerations, which often 
fail to conform to the standards required by importing countries. The materials are very rarely 
screened for active ingredient contents. Further, where materials are collected from the wild, 
investigations for adulteration need to be carried out. 
From time to time it has been proposed that cultivation would ensure higher quality for export. 
However, most attempts in the past which have resulted in production from cultivation relate tc 
aromatic plants and flavourings/spices. 
Cultivation of plants for herbal drugs in Pakistan, related to exports, has to date involved P/antago 
ovata, Menthapierata, Ocimum basil/cum, Diosoreasp., Ric/nus comm un/s. as well as flavourings 
such as coriander, garlic, and tumeric (Ahmad 1996). The Government's Export Promotion Bureau 
often combines statistics of medicinal plants with those of aromatics. Analysis of the statistics is 
not therefore very meaningful. 
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2.5 Constituents of Medicinal Plants 
Whereas around 250 to 300 species enter the herbal markets in Pakistan, approximately 500 
are known for their active constituents, either from research done in Pakistan or in other countries. 
Research has been carried out by PCSIR Laboratories in particular, as well as by some 
universities. The pharmaceutical industry has always been interested in plant sources from which 
finished allopathic drugs can be prepared or parts extracted to provide chemical constituents which 
form components of other drugs. Similarly, homeopathic factories emphasize constituents. 
A limited number of Pakistani drug companies do exist, notable examples being Hamdard, 
Kurram Chemical Company, Rawalpindi, and Marker Alkaloids, Quetta. However, companies in 
Pakistan are largely representatives of Western companies, mostly involved in packaging and 
labelling drugs as opposed to local research and development. There have been no government 
incentives to change this situation. 
One institution which, however, has adopted an innovative approach is the Institute of Chemistry 
under the University of Karachi, headed by Prof. Atta-ur-Rahman. Due to foreign funding, the 
Institute has been able to focus on commercially viable products using plant extracts, for example, 
essential oils from the spices mentioned above; constituents of Datura, Diosorea and Catharanthus, 
and about 17 other compounds. It has also become involved with pilot plant development. 
What is missing however is detailed and specific export market knowledge of who wants 
what, where and what prices are likely to be obtained. This is largely an international responsibility 
and some agency should be in a position to broker such deals to benefit developing countries. 
However, this is an issue for the government to raise with international organizations such as 
UNIDO and WHO. 
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Chapter 3 
The Tradihona Hedth 
The Unani system has been passed down over the centuries largely in the form of oral tradition. 
The practitioner is known as a Hakim Tabbib, meaning healer, and is the holder of a specialized 
body of knowledge. 
In Pakistan there are over 50,000 hakims. However, there is great variation amongst them: 
some are full-time professionals; others are simply knowledgeable about remedies for household 
and village use. The latter are known as YuriDosaks(often women), whose skills, involve diagnosis 
of illness from an assessment of the pulse and general appearance. Additionally, at the village level 
there are Dais (singular dai) who function as local midwives, aswell as bonesetters. They are 
unqualified practitioners. 
- 
There are 22 colleges in Pakistan providing education and training for hakims. Most offer a four 
year post—secondary school course. However, many of the hakims are not trained in this way. 
The practitioners are complemented by dispensers. However they are usually "C grade" 
pharmacists focusing on allopathy, and the system is not well regulated. 
In rural areas the choice between selecting an allopathic doctor and a hak/m depends on the 
availability of the practitioner; the availability of allopathic drugs and experience resulting from the 
benefit derived from either system. 
There is certainly a tendency for the older segments of the population to favour traditional 
medicine. However, studies do not provide' the data required to elucidate why certain traditional 
remedies are preferred over others. In part, this must relate to common knowledge regarding the 
medicinal plants occurring in a particular locality versus specialist knowledge of hakimswho possess 
a much broader knowledge base regarding the usage of medicinal plants. 
In the Unani system there is an inherent belief, following Galen, in the "temperament" of the 
drug-hot, cold, moist-and the 'temperament" of the patient. 
The Ministry of Health follows a system for registering medical practitioners through the 
1. Medical /Dental Council (for allopathic medicine) 
2. Pharmaceutical Council (for pharmacists) 
3. Unani Council (for traditional hakims), and 
4. Homeopathic Council (for homeopaths). 
However, of the 50,000 known hakims, only a small number is registered with the Council. There 
is no policy to prevent the "untrained" hakims from practising. 
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The Ministry of Health also has the stated aim of developing a traditional pharmacopoeia, 
though the only one currently available has been produced by Hamdard. Further, the Ministry 
insists that all herbal remedies be free of steroids as well as allopathic formulations, and in 
recognition of the need for authentication of the plant contents of herbal remedies, is as far as 
possible, promoting the listing of ingredients on packaging, as well as batch numbers inferring 
shelf life. While a start has been made in this area, there is a long way to go yet. 
With regard to authentication, the question of whether or not the efficacy conforms to the 
standards of allopathy in the West is somewhat irrelevant in situations where poor people cannot 
afford pharmaceuticals, a point stressed by Lambert eta/. (1997). These authors also point to the 
fact that "seemingly effective treatments exist for skin ailments, minor pain, infections, anaemia, 
other nutritional disorders and many more complaints that are mundane rather than life-threatening". 
Nearly 150 of the most commonly used herbal drugs in Pakistan have been standardized and 
knowledge of their constituents documented through the efforts of PCSIR. Whereas the policy' of 
the Ministry of Health which is not only of national but of international significance (Budeker 1995), 
is aimed at the promotion of traditional medicine, it is also imperative that it is safely utilized. In 
terms of local policy, a report for FAO produced in 1995 stated that Pakistani firms are not prepared 
to respond to the needs of an evermore conscious market (Saeed 1995). Hence the basic information 
provided by research is frequently not disseminated. 
Shelf life is extremely important since Unani medicines incorporate herbal, animal and mineral 
ingredients. Depending on the type of preparation, the storage containers are also important: 
"Itriphals" contain Embi/ca offic/na/i, Term/na/ia be/erIcaand Tchebulaas the major ingredients 
and require glass containers since astringency blackens metal. Pills and tablets, containing resins 
need coating and storage in airtight containers. Preparations containing volatile substances, for 
example, camphor, need to be kept in airtight containers. The Hamdard Phamacopoeia provides 
guidelines in this regard although these are certainly not applied fully by local druggists. 
3.2 Constraints to Promoting Traditional Medicine 
A number of scientists informed the authors that one of the weakest areas with regard to 
traditional medicine is that of diagnosis of diseases; This is an area beyond that of developing a 
vigorous medicinal plant sector in the country and is largely a question of education. The programme 
on traditional medicine carried out by the Ministry of Health lacks the funding and manpower to 
provide this. Consequently, workshops and seminars required to broaden the outlook of hakims 
and homeopaths in rural areas, and small booklets on prescriptions, are curtailed unless outside 
funding is made available. 
The question of quality control is another area which needs to be pursued. So far the government 
has not vigorously promoted quality control in practice, despite the fact that indigenous drug 
manufacture is governed by the Drugs Act. Standardization of indigenous drugs, which is essential, 
is an area in which the Hamdard Foundation has taken a lead. 
The wider availability of high quality standard preparations would go a long way to increasing 
confidence at the local level in the blending of diagnosis and therapeutics. 
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Nonetheless, quality considerations commence at the initial stage of collection of herbs. There 
is a lack of promotion and dissemination of scientific information available on collecting, harvesting 
methods, packing, storing and even grading material. Government institutions may well recognize 
this but the real lack of zealous extension from the agriculture and forestry lands to the village 
farmer level represents the major constraint. Concommitantly, this explains why technologies such 
as cultivation are not fully disseminated from the research institute level. 
Policy development at the government level could change the current situation. However, from 
the perspective of medicinal plants, this would have to span the Ministries of Agriculture, Environment 
and Forests, Science, Education and Health. 
13 New Development Directions 
Internationally, it has become widely recognized that extractive systems can only be sustainable it 
they are managed by local people. The traditional local associations or cooperatives are presently 
evolving into forest societies and community organizations with responsibilities for management, 
regulation and conservation. 
In Pakistan, the Aga Khan Rural Support Programme has developed a participatory approach 
in the northern areas of Chitral. This type of approach has been adopted as part of the Pakistan 
National Conservation Strategy. 
However, major gaps currently exist between the research being conducted on medicinal 
plants and rural development initiatives. Although the latter are being considered by conservationists, 
too much emphasis at present is being placed on the documentation of ethnobotany and not 
enough on prioritizing and using medicinal plants as a means of poverty alleviation. Some of the 
institutions conducting research have become involved in biodiversity surveys for conservation in 
association with the funding body, IUCN-Pakistan, which acts for the Ministry of Environment and 
Forests. However, while recommendations have been made, it remains to be seen whether or not 
these are fully put into effect by the local authorities. 
Institutional innovations for community development are a recent phenomenon which are still 
being discussed. There are still however a number of resource constraints. Possibilities and 
constraints were discussed as recently as May 1997 during a conference held in Islamabad, 
organized by the Organization for Islamic Conference Standing Committee on Scientific and 
Technological Cooperation (COMSTECH). However, schemes for community development must 
not only aim to revitalize the local economy, but also to save biodiversity, provide the poor with 
increased incomes, protect and capitalize on indigenous knowledge and respect and integrate 




Information and Coordination 
Major progress has been made over the past 35 years in documenting the medicinal plants of 
Pakistan. Simultaneously, reference specimens are currently available in a number of herbaria- 
the National Herbarium in Islamabad has become a focal repository for such collections. 
However, concurrent documentation of the usages of the medicinal plant species has not 
fared so well. This is due in part to the fact that a completed National Unani Pharmacopoeia is not 
available, although considerable credit has to be given to Hamdard for at least partially filling this 
major gap. To some degree, the gaps in information are due to uses being listed in research 
reports, frequently without any validation whatsoever, or without stated dosages or methods of 
treatment. 
The problem has been exacerbated over the past five years due to the fact that national interest 
in biodiversity has led to yet more and more listings of putative ethnobotanical uses without any 
attempt being made to investigate and verify beyond statements made during interviews, and no 
details being provided with regard to dosages, length of treatment etc. As a result, while hundreds 
of species are being added to the lists, especially with regard to home remedies, the essential 
details are lacking. In some cases attempts are being made to rectify this situation. For instance, 
a survey carried out by PFRI, Peshawar, in the northern mountainous regions identified plant species 
already known for their active principles. In addition, other species were sampled and sent to the 
Institute of Chemistry, University of Karachi for assessment (Zaidi 1997). 
4A General Constraints to information Flow 
Nearly all government institutions involved with medicinal plant research are constrained by 
lack of funding and manpower since staff vacancies tend to remain frozen. Their objective is to 
continue programmes initiated up to decades ago, without introducing new strategic planning 
methods to address urgent development and conservation needs, including poverty alleviation. At 
the same time, adequate mechanisms for the adoption of available technologies at the farmer or 
village level do not exist. 
The limited number of recent national workshops, in areas such as cultivation technologies or 
upgradation of the knowledge of hakims regarding medicinal plants, have not to date led to major 
changes. 
Moreover, when one particular institution acts as a focal point for regional networks, relevant 
information does not always flow to other institutions within the country. An example is the FAO 
Asian Network on Medicinal and Aromatic Plants. 
Furthermore, in order to develop a clear national policy, research institutions need to not only 
develop strategic planning but also to appreciate the constraints which result in slow action in the 
development field. 
31 
Priorities for Medicinal Plants Research and Development in pakistan , , 
4.2 Marketing and SocioEconomic rfQrnv 
Existing marketing data, which is in any case outdated, relates solely to prices in markets and 
amounts of raw materials required. New studies are therefore needed in this area. Markets are 
clearly imperfect in terms of price setting due to the restricted flow of information. Each 
transformation point needs to be understood with reference to the stakeholders involved, their 
functions and the horizontal and vertical market linkages. 
Studies have to deal with the whole chain of transactions from collectors through petty traders, 
private agents, wholesale dealers and finally consumers, No such studies are available in Pakistan. 
Furthermore, there are no adequate socio-economic studies relating to the participants, showing 
the extent of their reliance on their input to the chain of transactions and the manner in which their 
immediate dependents gain through their input. The collectors are almost certainly the poorest of 
the poor and any development interventions should attempt to improve their lot through their active 
participation as custodians of biodiversity. The collectors receive minimum wages and this situation 
will not improve until they have better access to information on prices, quality requirements, and 
timing of demand to enable them to plan their collecting activities. Almost certainly, stengthening 
the existing linkages between actors in the early stages of a production to consumption system 
would increase bargaining power for collectors and local traders. 
A number of studies from Nepal, including one conducted by Olsen-Smith (1996), would be 
invaluable for Pakistani researchers. 
Much of the trade and marketing, including movement of herbal products across borders, take 
place in the informal sector. It is not clear whether or not there are actual enforceable regulations 
for particular products. Most regulatory and policy interventions have concentrated on exports and 
little has been done to address the domestic market or the question of equity among diverse 
actors in the production to consumption system. 
43 nforrnation on Priorities 
There is no priority listing agreed on by the majority of researchers as to which are the most 
important medicinal plants on which to focus. Although the national pharmaceutical industry 
concentrates on about 20 species, the consideration is, primarily commercial. Priority setting has 
to include a number of criteria including the threat of genetic erosion; value to the overall economy, 
including local people; value in local and traditional health care systems and sustainable use 
extending into the future, amongst others. 
This lack of priority listing stems from the lack of a central computerised information 
database incorporating commercial values, status regarding degrees of overexploitation in the 
wild, health care needs, rural community development needs and information on patterns of 
variation within species. Some proposed interventions are outlined later in this report. 
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&4 Access of Researchers to nforrnaton 
For a number of reasons, most institutions researching medicinal plants do not appear to have 
links, except in passing, to ongoing activities in other countries. India for instance has two important 
computerised databases. One is the bimonthly "Medicinal and Aromatic Plants Abstracts", under 
the auspices of the Council of Scientific and Industrial Research, which scans 600 journals from 
55 countries. Another Indian national database, IMMEDPLANT, covers activities of research 
institutions relating to medicinal plant taxonomy, phytochemistry, pharmacognosy, agro-technology 
and traditional medicine. 
The FAO regional network has been mentioned earlier. In addition, there is also a UNESCO 
network as well as the Asia-Pacific Information Network on Medicinal and Aromatic Plants, estab- 
lished in 1987. Although Pakistan is a member of the latter network, information flow to national 
institutions is not as efficient as it could be. 
A more recent network, the IDRC Medicinal Plants Network, now known as the Medicinal and 
Aromatic Plants Program in Asia, with headquarters at the regional office of the International Devel- 
opment Research Centre (Canada) in New Delhi, focuses on research and networking with spe- 
cial reference to targeting the very poor; the well-being of women and poverty alleviation. It has only 
recently established links with Pakistan in 1996, when a workshop on the role of bamboo, rattan 
and medicinal plants in mountain development was help in Pokhara, Nepal. 
The IDRC network has issued a Code of Conduct for researchers involved in the study of 
various aspects of medicinal plants. (See Appendix 2), and a declaration concerning mountain 
development (see Appendix 3). Both provide useful guidelines for institutions in Pakistan for devel- 
oping strategic planning methods in relation to medicinal plants. The declaration shown in Appen- 
dix 3 stresses the need for networking and information dissemination in the region, just as the 
regional political grouping, SAARC, stresses the same for genetic resources of useful plants. 
45 !nformation on Toxcoogy 
There is a need to ensure that plants used as drugs by rural people are not toxic in any way. 
Whereas for Unani preparations, this is not an urgent concern since tradition has over time re- 
sulted in standard preparations, it is especially true for those plants, which are widely used as 
home remedies and for which ethnobotanical studies are producing ever-expanding lists of spe- 
cies. However, until methods of use arid preparation are firmly integrated with ethnobotanical data, 
and until validation and recommendations for standard preparations are made for these herbs, 
there is a moral need to emphasize safety concerns pending toxicological studies. 
There is a WHO publication, entitled "Research Guidelines for Evaluating the Safety and Effi- 
cacy of Herbal Medicines," published in 1 993, which will be of great value to Pakistani institutions. 
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Chapter 5 
Towards a Sustainable Medicinal Plants Sector in Pakistan 
This report has shown that there is long-standing research on medicinal plants in Pakistan 
and a growing, albeit fragmented, information base. This, coupled with a strong classical tradi- 
tional medicine sector which provides employment (although as yet unquantified) and health care 
(especially in rural areas), reveals that there are clear opportunities to focus future efforts on the 
following areas: 
• Poverty alleviation of rural and tribal communities which are involved in harvesting and col- 
lecting medicinal plants through the development of well designed partnerships between sci- 
ence and development; 
• Environmental and biodiversity conservation - with efforts linked to incentives for sustainable 
management, rehabilitation of degraded ecosystems and genetic conservation of priority 
medicinal plant gene pools, and; 
a Rationalization and increased share of international trade in raw medicinal plants, which will 
require government policies and incentives. 
The medicinal plant sector spans: 
a The Government of Pakistan and its research organizations; 
• Provincial Governments and their extensions; and 
• The Private Sector dealing with Unani preparations and traditional medicine practice. 
If this base is broadened to include internationally and regionally available information, on the 
one hand, and relevant non-governmental organizations involved with the communities which col- 
lect and use the plants on the other, then new and effective partnerships will emerge. 
However, at present, there is no definable medicinal plants sector. A number of important 
research and development activities could ultimately lead to changed perceptions of different 
stakeholder groupings. They may also lead to clearer policies which affect the sector, such as 
regulations on trade practices and promotion of innovative conservation and utilization of medici- 
nal plants. Activities have to be proposed and implemented on a multidisciplinary front, and a 
number of proposals are offered below. 
51 Consolidation of the Plant Resource Information Base 
Not only is there wide floristic diversity of medicinal plants in Pakistan but herbs enter the 
sectors of traditional medicine; industry, as raw materials, whether or not they are pharmacologically 
active, or as essential oils, tannins, gums and other substances; the food industry for cooking and 
colourants; and the cosmetic industry. 
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There is therefore an urgent need to consolidate information on all known taxa of medicinal 
plants of Pakistan's flora in an interactive database which includes distribution; rarity; ecological 
data; their use in medicine whether or not this is validated; active principles identified; which types 
of preparations are used in medicine; dosages etc. used and pharmacopoeial references. To these 
have to be added estimated degrees of genetic erosion of populations and conservation efforts 
insituand exsitu. A considerable amount of relevant data exists but is mostly scattered. Consoli- 
dation would thus identify gaps in knowledge and permit a strategic focus on future field surveying. 
A focal point for this information-gathering could be the National Herbarium as has previously 
been suggested at national meetings. With the availability of suitable funding, the task could be 
completed in 18 months. 
To illustrate the value of a database, the status of medicinal plants should be considered. In 
Swat, out of a total of 350 species, 5 species are endangered, 16 are threatened and 18 are 
vulnerable (Ahmad and Sirajuddin 1996). Information is not readily available as to whether or not 
these are all under threat elsewhere. Certainly, some are common in other parts of the country. 
Only with the availability of reliable data, and interpretation of this data, can valid conservation 
targets, other than broad in situ conservation of ecosystems be set. However, if populations of 
species are so impoverished, rehabilitation action will be needed (see 5.5). 
5.2 Assessing Markets 
The production to consumption system flows vertically from the collectors to the final consum- 
ers. A series of actions occurs for any natural product - it may be processed, spoilage prevention 
is needed and the "raw" or "processed" product may be consumed, marketed for direct consump- 
tion or used as an input to a manufactured product. At each stage, the produce is bought and sold. 
For medicinal plant products the interaction between the various actors involved appears to be 
more significant than the degree of processing. 
The market is also heterogenous. Medicinal plant products are sold in small local markets in 
the same areas where large traders amass their supplies for industry, and occasionally for export. 
Many cross national borde in an "informal" way. 
Existing data on quantities available in markets at any particular time do little to help clarify the 
complex commerce of medicinal plants. Up-to-date analysis is required even though the informal 
market is very difficult to evaluate. Nonetheless, this informal market has to recognize conserva- 
tion imperatives, and attempts made in this direction will only result from estimates of the informal 
market. Analysis of market information could lead to clear attempts to stem adulteration, as well as 
priority setting for ensuring sustainable supplies of raw materials. The current unsustainable har- 
vesting practices, mostly unregulated, are due not only the poor knowledge of the collectors of the 
plants and their ecologies, but also to the inadequate dissemination of price information. 
For a suitable study to be conducted, a limited number of raw materials would have to be 
tracked and these would have to be selected on the basis of their being indicative of much larger 
groupings of herbs. 
Concurrently with the analysis of market transformation points, socio-economic implications 
would require assessment in relation to benefits accruing to communities and the relative roles of 
gender, on-farm/off-farm incomes etc. 
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It is estimated that such a study would take a 2 year period to complete. It would need a 
steering committee and an expert on modern participatory socio-economic research. 
5.3 Urgent Salvaging of Priority Genetic Resources 
and their Evaluation 
Many important medicinal plants have dwindling populations. It is therefore, critical that materi- 
als are collected and conserved in the most appropriate way, using seed storage in the national 
genebank where possible, and vegetative storage in ex situ collections for study, evaluation and 
selection of superior types. Some of the material will be valuable and appropriate for enrichment 
planting, especially in forested areas. 
The key to success will be the sampling strategy used, and this must focus on populations 
rather than taxa. The National Plant Genetic Resources Institute is the obvious focal point for this 
work until such time as the forest research organizations are equipped for conducting genetic 
resources work. There will be a need to firstly identify priority species, and secondly priority areas. 
Priority Species 
A number of major medicinal plants are already recorded as being scarce or rare, or becoming 
increasingly so. They include in the northern parts Podophyl/um emodi Rheum emod Va/er/ana 
wa///chh' A#emis/a species, Acorus ca/amus, Saussurea lappa, Paeon/a emodj Ephedra species, 
Carthamus t/nctor/us, Dioscorea species, Hyoscyamus ni'ei Pterocarpus inarsup/ani, Atropa 
acum/nata and Coich/cum luteum. Of these, ArtemL$ia, Ephedra and Va/er/ana are of major impor- 
tance to the pharmaceutical industry in the country. All are of major value in traditional medicine. 
Most medicinal species which are also fruit trees are not under threat since these are main- 
tained or protected by local people. Others, already domesticated as crops such as cumin, anise 
and safflower are also to be considered somewhat differently from wild species. However, their 
supply can be erratic as in the cases of Pimp/ne//a an/sum in Punjab, and Cum/num cym/num in 
Baluchistan, North West Frontier Province (NWFP) and Punjab. For these and other species, the 
need for genetic resources evaluation is urgent and should be prioritized as part of the national 
genetic resources programme. 
In many parts of Pakistan, plants used for their roots are becoming increasingly scarce, for 
example, C/ssampe/ospareira and W/than/a somn/fera in Punjab and Sind, and Murraya koenig/i 
and Sphaeranthus ind/cusin Punjab. Certain species are similarly becoming rarer, for example, 
Fumariaparv/flora in Baluchistan. So too are many arid zone medicinal species. 
Priority Areas 
In terms of guaranteeing sustainability of herbal supplies arid meeting conservation needs, the 
undisputed priority areas are forest areas in the northern part of the country (North West Frontier 
Province (NWFP), and Azad Kashmir). These undoubtedly include the Kalash and Kafristan valleys 
of Chitral; the Bogaranang/Sirren valleys; Kaghan valley and the Swat, Dir and Kurram valleys. 
These are also areas where poverty alleviation is an important issue in relation to tribal people. 
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A second priority area would include the drier forested areas of Baluchistan, while a third 
priority region would encompass certain parts of the Cholistan and Tharparker deserts. 
Proposed Action 
The National Plant Genetic Resources Programme, in collaboration with other institutions 
working in areas such as validation of active principles when evaluating germplasm, should de- 
velop a phased project for donor funding over a three year period. This should include activities 
such as collecting, conservation and evaluation. 
54 Urgent !mpernentation of Cultivation 
There is no national overview in the country with regard to which species should be cultivated, 
though numerous suggestions have been made at the institutional level and even promoted through 
research and development in this respect. Although trials have been carried out by the Forestry 
Institute since the 1 960s, few recommendations have actually been adopted. Conservationists, for 
example Naim (1996), are also concerned about this issue. Appendix 4 lists examples of species 
for which appropriate cultivation technologies are already available. This would probably apply to 
at least 40 species occurring in Pakistan, including traditional methods of cultivating mint, anise 
and other aromatic herbs and spices. 
Cultivation will result in improved supplies of raw materials, provide an alternative to collecting 
planfs from the wild, and will also lead to standardization. 
Promotion of cultivation is intrinsically linked to the following activities: 
1. Evaluation of genetic resources and identification of suitable genotypes for cultivation (this is 
an integral component of 5.3 above) 
2. Development of farming systems compatible with local food cropping systems,with an em- 
phasis on promoting income generation for a broad section of local communities. 
3. Application of multiple cropping/agroforestry and other types of farming systems ic suit agro- 
ecological aspects of the target medicinal plants. This would include the provision oi partial 
shade and support, and sequential harvesting of crops over a 3 to 8 or 10 year period, (See 
also Gohar 1994 and Shinwari 1993 who emphasize the point that agroforestry should con- 
currently address Constraints of fuelwood shortages and multipurpose use.) 
4. Selection of species with known medium to high market value. At prevailing rates, production 
of Podophyllum emodfwoud result in prices per ton which are twice that of Saussurea and six 
times that of Valer/ana. Depending on market prices and harvesting cycles, mixed (sequen- 
tial) cropping would be essential. Species currently thought to be appropriate for cultivation 
are shown in Table 10. This table is an attempt to list those species emphasized in scattered 
research reports which would form a core group in a priority setting. 
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5. Farming and rural communities have a major role to play in accepting, promoting and sustain- 
ing cultivation practices. Thus all programmes in this regard need to be devised within a 
framework of rural development since cultivation, storage, post-harvest protection and mar- 
keting are all integral aspects to be considered. 
Table 10 Tentative Priority Species for New or Enhanced Cultivation 
* Further research and development work required for cultivation: 
A. Species widely used 
* A con/turn napellus 












Saussurea lappa (syn. S. costus) 
So/anum khasianum 
Va/er/ana wa/llch// (syn. V jatarnansi) 




Propagation for cifitivation 
Cultivation is only successful when high quality planting materials is available. Hence cultiva- 
tion not only provides an alternative raw material production system, thus reducing the he.avy over- 
exploitation of many important commercial medicinal species, but also improves quality supply. 
Some species can be readily propagated using seeds, but in most cases, the adoption of this 
technique would result in heterogenous populations. Vegetative propagation leads to more reliable 
stands and yields. In some cases, for example Podophyllurn and Saussurea, where ramlets are 
slow growing, tissue culture techniques would have to be promoted. The National Plant Genetic 
Resources Institute has facilities for research and development in this area. Tissue culture tech- 
niques exist elsewhere for Atropa acurn/nata, Dioscorea de/to/dea, Mentha sp, P/crorrhLza kurroa, 
Rheurn emod/and many other species of interest which occur in Pakistan. 
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Proposed Action 
Depending on the priorities determined under section 5.3, as well as market demands, a project 
should be developed involving the participation of suitable NGOs to cultivate and market important 
species. This is likely to attract donor funding for a three year period, renewable for an additional 
two years. 
5.5 In Situ Conservation and Continued Upgrading of Forestry 
Practices to Conserve Species Occurring in Specific Ecosystems. 
This report has described strategies used in forest management, related to the new focus on 
biodiversity conservation whereby certain areas would be deemed as strict reserves where 
harvesting of non-timber forest products would be prohibited for a period of several years to allow 
for some regeneration. Such efforts are only to be applauded. However, it is equally important to 
ensure that these efforts are paralleled by clarification of resource tenure rights, with adequate and 
acceptable prOvisions being made in relation to fuelwood, fodder and extraction of medicinal plants. 
This involves the active participation of local community organizations and NGOs. Additionally, it 
must be recognized that a number of scientists have expressed the opinion that in situ conservation 
of ecosystems in Pakistan is unlikely to be adequate for the future protection of large segments of 
biodiversity. 
In a number of cases, efforts would need to be supported by rehabilitation of a number of non- 
timber forest products using local germplasm. Community involvement in this regard, coupled 
with education, provides a pro-active approach to conservation, especially in light of self-evident 
future benefits. Responsibility in this area should lie within the existing cooperative efforts between 
PFI, Provincial Forest Departments, and national efforts focusing on biodiversity, in association 
with IUCN and WWF. Conservation is a national responsibility as outlined in Agenda 21 and the UN 
Convention on Biological Diversity. 
It is important to recognize that regeneration of medicinal species within ecosystems, and 
cultivation of selected genotypes in agricultural systems are separate strategies requiring appro- 
priate coordinated planning. In the former case, the objective has to be to maintain as much local 
natural genetic variation as possible. In the latter case, production is likely to be limited to specific 
segments of the overall pattern of variation of the genepool. It is thus vital that exsitu conservation 
complements both rehabilitation of ecosystems as well as attempts at cultivation, as mentioned in 
section 5.3 above. 
5.6 Ex Situ Conservation for Medium to Long-Term Benefits. 
The importance of the national genebank cannot be overstated since the institution which 
maintains it has state-of-the-art facilities for seed storage and tissue culture. Salvaging genetic 
resources (5.3 above) and evaluating them (5.3 and 5.4) require methodologies and facilities which 
already exist and which need to be applied to medicinal plants. 
For example, it is widely known that the handling of seeds, from their initial collection in the 
field, has a profound effect on subsequent germination and sustaining viability. Many previous 
experiments conducted on germination of seed lots for medicinal plants are meaningless without 
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the availability of data on seed moisture content, methods of temporary storage, drying etc. Similarly, 
collecting vegetative materials, (rhizomes, corms, cuttings etc.), especially when used for 
experimentation, requires sampling data to extrapolate results regarding population variability, since 
biased sampling can lead to incomplete results. Many published papers in this area lack the 
sampling data. 
For ex situ conservation, it is to be expected that a large proportion of priority species will 
possess orthodox seeds, that is, seeds which can be dried and conserved at low temperatures in 
a genebank. Collections of growing plants can also be built up in exsitu field genebanks. For the 
species likely to be accorded priority, the Karakoram Agricultural Research Institute for the North- 
ern Areas, is the obvious choice of location for a major ex situ collection. Other locations will be 
required in different agro-ecological zones as medicinal plant conservation and utilization is ex- 
panded, and these will require full documentation related to any materials in the national genebank 
or in protected areas. 
51 Policy and Education 
Clearer government policy is likely to emerge as a result of the actions proposed in sections 
5.1 to 5.6 being vigorously pursued. However, under the present national funding climate, outside 
donor funding should be mobilized to initiate the proposed strategic actions, and national funding 
sought to strengthen or sustain specific inputs by individual institutions. 
Though not itemized in this report, there are urgent requirements for education on a broad 
front. There is a major need to train the collectors and traders of medicinal plants to ensure better 
quality, and this should involve practitioners of traditional medicine. At present, orders placed for 
raw materials are based on vernacular names, and this point alone presents problems in cases 
where the same vernacular can apply to more than one species, or where species have similar 
vernacular names. 
Since the education required is on such a broad front, it will have to be tackled on a large-scale 
basis. For instance, once an integrated database is made available, numerous pamphlets can be 
generated containing appropriate information relevant to the recipient. These can interface with 
conservation imperatives and projects, as well as the specific interests of diverse Ministries. 
Furthermore, a community participation approach to cultivation, will need an educational compo- 
nent. NGOs such as the AKRSP, which has been active in the Northern Areas and in Chitral 
since 1982, as well as Sarkad RS Corp which is working in other provinces, will be vital in devel- 
oping appropriate priority interventions in specific priority areas. If training experience is gained 
within such a framework, it is likely to be more widely replicable. 
It is not clear as to the extent of the need for collections of medicinal plants primarily for educa- 
tional purposes. However, due consideration will have to be given to this issue in a number of 
diverse climatic areas. Further, the greater the linkages with demonstrations of new streamlined 
supply systems, the more successful these collections will be, especially in areas where several 
local languages are used and where literacy rates are very low. 
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5.8 Future Prospects 
There will almost certainly be a need for stronger coordination of the medicinal plants sector at 
the national level. However, the establishment of a national committee, inter-ministerial dialogue or 
whatever mechanism is deemed necessary, is more likely to be successful if appropriate strategic 
action (as proposed above) has already been taken at the research and development level. 
The objective is not simply to forge links and collaboration between interested research parties 
in the country but also to encourage sustainable development through the adoption of strategies 
involving income generation, conservation and target-oriented use of the resource base as deter- 
mined by socio-economic and health considerations. 
In the meantime, it would be prudent for the relevant government authorities to address the 
following issues: the validity of CITES recommendations and listings of plants or derivatives re- 
stricted for export; wider participation in regional networks and maybe membership in others such 
as the G-1 5 Genebanks for Medicinal and Aromatic Plants (GEBMAP); the policy environment of 
non-timber forest products and community rights; investment in the private pharmaceutical sector 
and expanded education and information flow to hak/ins. The addressing and clarification of any- 
one of the above tasks, all of which require attention on the domestic front, will facilitate progress 
towards a viable and sustainable medicinal plants sector in Pakistan. 
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Major Herbal Drug Dealers in Pakistan 
(from Marwat, 1996) 
DIR AND SWAT, NWFP 
1. Messrs. Haji Tehmas Khan, Drug Dealers, Main Bazaar Dir., NWFP. 
2. Ahsami Dar-Ul-Advia, New Bazaar, Dir., NWFP. 
3. Messrs. HAJI Fareedoon, Drug Dealers, Main Bazaar, Dir., NWFP. 
4. Messrs. Haji Faiz-Ulla Brawal Barida, DIr., NWFP. 
5. Messrs. Habib- Ullah Khan, Dir Commission Shop, Batkhella, NWFP. 
6. Messrs. Abdullah Jan and Rahmat Gui, Madyan Road, Mingora, Swat, NWFP. 
7. Messrs. Abdullah Jan and Rehmat and Co., Madyan Road, Mingora, Swat, NWFP. 
8. Messrs. Hakim Dilber Khan, Swati Ghee Depot, Madyan Road, Mingora, Swat, NWFP. 
9. Messrs. Syed Au Mirza Abasin Kohistan Trading Co., Madyan Road, Mingora, Swat, NWFP. 
10. Messrs. Asghar Au Swat Trading Co., Kanju Road, Mingora, Swat, NWFP. 
11. Messrs. Inam GuI Drug Dealer, Bahrain Road, Bahrain, Swat, NWFP. 
12. Messrs. Pir Mada & Co., Bahrain, Swat, NWFP. 
13. Messrs. Toti Gui, Bahrain Road, Bahrain, Swat, NWFP. 
14. Messrs. Danish and Sons, Madyan, Swat, NWFP. 
15. Messrs. Haji Shahjan, Anwar & Co., Madyan, Swat, NWFP. 
16. Messrs. Muhammad Safdar, Punjab House, Madyan, Swat, NWFP. 
17. Messrs. Halim Khan, Bazaar Timmergarah, Dir, NWFP. 
18. Haji Mohsin Khan Khai, Dir, NWFP. 
19. Messrs. Daya Singh, Main Bazaar, Pir Baba, Buner, NWFP. 
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20. Messrs. Fazai-Khaiiq Modern Industries, International Traders, Modern House, Mingora, 
Swat, NWFP. 
PESHA WAR, NWFP 
21. Messrs. Haji Ahmed & Sons, Daigran, Peshawar, NWFP. 
22. Messrs. Muhammad Younas, People Mandi, Peshawar, NWFP. 
23. Messrs. Nazir Gui, Shopkeeper, People Mandi, Peshwar, NWFP. 
24. Messrs. Saeed Sons, People Mandi, Peshawar, NWFP. 
25. Messrs. Malik & Co., Namak Mandi, Peshawar, NWFR 
2.6. Messrs. Qamar Traders, Namak Mandi, Peshawar, NWFP. 
27. Messrs. Mau moor & Co., Meva Mandi, Peshawar, NWFP. 
28. Messrs. Afghan Trading Co., Meva Mandi, Peshawar, NWFP. 
29. Messrs. Haji Loung Khan, Munawar Khan, Daigran, Peshawar, NWFP. 
30. Messrs. Muhammad Ayaz & Co., People Mandi, Peshawar, NWFP. 
31. Messrs. Haji Abdur Rehman & Sons, Daigran, Peshawar, NWFP. 
32. Messrs. Haji Rehman Gui, Dalgran, Peshawar, NWFP. 
33. Messrs. Abdur Rehmari and Abdur Rahim Siddiqui, People Mandi, Peshwar, NWFP. 
RAWALPINDI, PUNJAB 
34. •Anis Brothers, Naswari Bazaar, Ganj Mandi, Rawaipindi, Punjab. 
35. Kha(id Rashid & Co., Naswari Bazaar, Ganj Mandi, Rawaipindi, Punjab. 
36. Mosa Javeed & Sons, Naswari Bazaar, Ganj Mandi, Rawalpindi, Punjab. 
37. United Karyana Store, Naswari Bazaar, Rawaipindi, Punjab. 
38. National Karyana Stores, Naswari Bazaar, Ganj Mandi, Rawaipindi, Punjab. 
39. Golden Store, Naswari Bazaar, Rawaipindi, Punjab. 
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LAHORE, PUNJAB 
40. Batala Trading Co., Akbari Mandi, Lahore, Punjab. 
41. Muhammad Store, Akbari Mandi, Lahore, Punjab. 
42. Java Pansari Store, Akbari Mandi, Lahore, Punjab. 
43. Ch. Farzand All, Paper Mandi, Lahore, Punjb. 
44. Sheikh Au Muhammad & Ghulam Sarwar, Akbari Mandi, Lahore, Punjab. 
45. Asad Traders, Akbari Mandi, Lahore, Punjab. 
46. Atiq Karyana Store, Akbari Mandi, Lahore, Punjab. 
47. Kausar Karyana Store, Akbari Mandi, Lahore, Punjab. 
48. Sheikh Noor Hussain, Akbari Mandi, Lahore, Punjab. 
49. Abdul Majeed & Saeed Ahmed, Akbari Mandi, Lahore, Punjab. 
50. Khursheed Au Karyana, Akbari Mandi, Lahore, Punjab. 
51. Arif Brothers, Akbari Mandi, Lahore, Punjab. 
52. Zahoor Sons, Akbari Mandi, Lahore, Punjab. 
53. Jameel Traders, Akbari Mandi, Lahore, Punjab. 
54. Madina Traders, Akbari Mandi, Lahore, Punjab. 
55. Hidayat & Co., Akbari Mandi, Lahore, Punjab. 
FAISALABAD, PUNJAB 
56. Messrs. Jamal Din * 11am Din, Goal Karyana Bazaar, Faisalabad, Punjab. 
57. Sheikh Ibrahim & Sons, Goal Karyana Bazaar, Faisalabad, Punjab. 
58. Sabri Karyana Store, Gaol Karyana Bazaar, Faisalabad, Punjab. 
59. Rajpoot Karyana Store, Gaol Karyana Bazaar, Faisalabad, Punjab. 
60. Saeed Brothers, Gaol Karyana Bazaar, Faisalabad, Punjab. 
61. Haji Mehar Din, M. Abdullah, Goal Karyana Bazaar, Faisalabad, Punjab. 
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MULTAN PUNJAB 
62. Messrs. Batala Karyana Store, Haram Gate, Multan, Punjab. 
63. Messrs. Muhammad Hussain, Abdul Rehman, Beroon Gate, Multan, Punjab. 
64. Haji Usman & Sons, Bazaar Chauri Saray, Multan, Punjab. 
65. Haji Mushtaq Ahmad, Bazaar Chauri Saray, Multan, Punjab. 
66. M. Bashir, M. Safeer, Bazaar Chauri Saray, Multan, Punjab. 
67. Abdul Aziz Karyana, Bazaar Chauri Saray, Multan, Punjab. 
68. Mehraj Din, Mushtaq Ahmed, Gur Mandi, Multan, Punjab. 
69. Waheed & Co., Harm Gate, Multan, Punjab. 













Boor Muhammad & Manzoor Ahmed Pansari Store, Chock Bazaar, Bahawalpur, Punjab. 
Molvi Hidayat Muhammad & Sons, Machli Bazaar, Bahawalpur, Punjab. 
Asif Zia Karyana Merchant, Fateh Khan Bazaar, Bahawalpur, Punjab. 
Chaudhri Karyana Merchant, Fateh Khan Bazaar, Bahawalpur, Punjab. 
Maqbool Ahmed Karyana Merchant, Fateh Khan Bazaar, Bahawalpur, Punjab. 
Abdut Rashid & Abdul Basit, Fateh Khan Bazaar, Bahawalpur, Punjab. 
Javed Karim Bazaar, Jamay Masjid, Bahawalpur, Punjab. 
Umer Din Abdul Ghani, Fateh Khan Masjid, Bahawalpur, Punjab. 
Haji Umer Din Muhammad Ishaq, Bazaar Fateh Khan, Bahawalpur, Punjab. 
Abdut Rashid, Muhammad Munir Merchant, Bazaar Fateh Khan, Bahawalpur, Punjab. 




82. Yousaf Brothers, Karyaria Bazaar, Sukkur, Sind. 
83. Ahmed Khan & Co., Karyana Bazaar, Sukkur, Sind. 
84. Haji Abdul Sattar & Haji Usman, Shahi Bazaar, Sukkur, Sind. 
85. Jan Muhammad & Abdul Ghafoor, Karyaoa Bazaar, Sukkur, Sind. 
86. Haji Zakria Ahmed Pansari, Karyana Bazaar, Sukkur, Sind. 
87. Muhammad Ibrahim Karyana Merchant, Karyana Bazaar, Sukkur, Sind. 
88. G.H. Umer, Karyana Merchant, Karyana Bazar, Sukkur, Sind. 
89. Narani Pansar, Karyana Bazar, Sukkur, Sind. 
90. Ashraf Anis & Co., Karyana Bazaar, Sukkur, Sind. 
91. Muhammad Hanif and Brothers, Karyana Bazaar, Sukkur, Sind. 
HYDERABAD, SND 
92. Chamber of Commerce, Chandni Cinema, Hyderabad, Sind. 
93. Nabi Bakhsh & Co., Market Road, Hyderabad, Sind. 
94. Haji Umer Din, Haji Allah Rakkha, Market Road, Hyderabad, Sind. 
95. Sikandar Ali Karyana Merchant, Market Road, Hyderabad, Sind. 
96. Ramzan Au & Muhammad AIim Brothers, Market Road, Hyderabad, Sind. 
97. Ramzan Ali & Brothers, Market Road, Hyderabad, Sind. 
98. Abdul AU & Brothers, Market Road, Hyderabad, Sind. 
99. S: Mehar Ali Karyana Merchant, Market Road, Hyderabad, Sind. 
100. Din Muhammad Karyana Merchant, Market Road, Hyderabad, Sind. 
101. Jamal Bahi & Ibrahim and Sons, Market Road, Hyderabad, Sind. 
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KARACHL SIND 
102. Baqai & Co., Judia Bazaar, Karachi, Sind. 
103. Hussaini Corporation, Judia Bazaar, Karachi, Sind. 
104. M. Jamil & Sons, Muhammadi Street, Karachi, Sind. 
105. Hakim & Co., Judia Bazaar, Karachi, Sind. 
106. Nayab-ud-Din, Judia Bazaar, Karachi, Sind. 
107. Haji Pir Purkhash Corporation, Judia Bazaar, Karachi, Sind. 
108. Yousaf Karim, Judia Bazaar, Karachi, Sirid. 
109. Awan Traders, Au Akbar Street, Judia Bazaar, Karachi, Sind. 
110. Karim Co., Darya Lal Street, Judia Bazaar, Karachi, Sind. 
111. Au Muhammad Bilal, Judia Bazaar, Karachi, Sind. 
112. Musarrat Traders Corporation, Judia Bazaar, Karachi, Sind. 
113. Abu Bakar & Sons, Judia Bazaar, Karachi, Sind. 
14. Muhammadi General Store, Judia Bazaar, Karachi, Sind. 
115. Insaf Karyana Store, Judia Bazaar, Karachi, Sind. 
116. Hussaini Store, Judia Bazaar, Karachi, Sind. 
117. Haji Usman Bilal, Judia Bazaar, Karachi, Sind. 
118. Musleh-ud-Din & Sons, Judia Bazaar, Karachi, Sind. 
119. YousafAli, Qamar-ud-Din, Judia Bazaar, Karachi, Sind. 
120. Capri Traders, Judia Bazaar, Karachi, Sind. 
121. Muhammad Jumma & Sons, Judia Bazaar, Karachi, Sind. 
122. Producer Co., Judia Bazaar, Karachi, Sind. 
QUETTA, BALUCHSTAN 
123. Farooq Traders, Importers Exporters & Dry Fruit Commission Agents, Shahra-e-lqbal, 
Quetta, Baluchistan. 
124. Chaudhri Muhammad Ali & Co., Importer Exporter Commission Agents, Shahra-e-lqbal, 
Quetta, Baluchistan. 
125. Wattan Trading Co., Dry Fruit Commission Agents, Shahra-e-lqbal, Quetta, Baluchistan. 
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Code of Conduct on Medicina' P'ant Research 
PREAMBLE 
The participants of an IDRC - sponsored meeting on Medicinal Plants Research in Calicut, India, 
6-8 February, 1995, have noted that: 
Whereas p/ants have been the source of food and med/c/ne throughout h/story and; 
Whereas radit/ona/ systems of med/c/ne have emp/oyed medic/na/p/ants for pr/mary health care 
purposes, and; 
Whereas approximately 80 percent of the world's popu/ation is dependent upon traditiona/ andfo/k 
systems of med/c/ne for pr/mary health care, and, 
Whereas an /ncreas/ng number of med/c/na/p/ants are being approved by governments /n deve/- 
oped and deve/oping countr/es for use in pr/mary health care delivery systems, and; 
Whereas there is a great need to increase awareness of the va/ue of med/c/na/p/ant b/diversity 
and associated know/edge and; 
Whereas the supp/y of med/c/na/p/ants in the South Asian region, comb/ned with absence of 
standards for crude drugs resu/ts in the prevalence of adulteration and substitution, and; 
Whereas there are at least 55,000 ilcensed pharmacies and companies utllLzing medic/na/p/ants, 
and,' 
Whereas Many traditional herbal medicines are relatively/ow/n cost, 
A nd agreed as follows: 
ARTICLE 1 Origin of medicinal plant materials 
Plant material will be properly documented with respect to identity and location of source. 
ARTICLE 2 Collecting material and quality specifications for fresh. dried and processed 
plant materials. 
In view of the existing over-exploitation of many medicinal plant species, standards will be agreed 
upon for the collection of each species. Standards will relate to the part of the plant collected, stage 
of development and timing of collecting. As far as possible these standards will accord with au- 
thoritative publications. 
All aspects of processing will accord with agreed procedures and be related as far as possible to 
authoritative texts. These aspects will include storage of plants, time of processing, methods used 
(solvents, heat etc.), including equipment, standards of clearness to reduce microbial contamination 
and storage of extracts. Limits of other plant parts, in addition to the target plant part will be set, as 
will the limits for foreign mineral matter. Where such standards or procedures are not widely 
documented they will be developed through research. 
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ARTICLE 3 Characterization of therapeutic value and information on use and con- 
stituents 
All research on herbal medicines must document the accepted value of the plant-derived material 
in human health benefits. 
Dosages, i.e. form (powder, decoction etc.), amount, and timing of dosage will be documented 
with specific details of processing and preparation. Forms of preparation relate to one or more of 
powdered plant materials, extracts, purified extracts or partially purified active substances isolated 
from plants. Routes of administration are also to be documented. 
Active constituents, as far as they are known, should be stated and their structural formulae given. 
However, in many cases, the plant preparation as a whole is therapeutically effective even though 
active principles are not known. Such 'crude' preparations are recognized as useful and docu- 
mented in texts because activity may depend on a large number of components. 
In single plant remedies contents of known therapeutically active constituents should be deter- 
mined and acceptable dosage range specified for the health systems in which the remedy is used. 
When the medicine is a herbal mixture, the most characterizing compounds should be described. 
ARTICLE 4 Documentation of therapeutic uses 
Documentation of therapies for specific diseases and maladies should include status of use of 
medicinal plants in therapy (in the past, current or changes proposed) and also adjunct therapies, 
such as diets, life style modifications, baths, psychological or ritual treatments. 
Disorders treated may include folk terms and maladies which are culturally defined. 
Data on therapy should be supplemented by criteria for diagonizing the disease or malady and also 
by relating the therapy to the stage of the disease. 
ARTICLE 5 Toxicity of herbal medicines 
It is recognized that toxicological investigations are required to supplement human experience in 
defining possible toxicity of herbal preparations. Where this is not documented in authoritative 
texts, the WHO research guidelines are appropriate. 
ARTICLE 6 Clinical trials 
Clinical trials are used to validate efficacy, to develop new medicines, to revise dosage formula- 
tions and to test activity of extracted purified or crude compounds. In this respect, the WHO 
research guidelines are appropriate. 
ARTICLE 7 Pharmacological studies of herbal medicines 
Non-clinical studies may be required to determine whether the clinical use of a herbal medicine is 
valid, to characterize its range of pharmacological actions or to study pharmacologically active 
products/compounds. In this respect, the WHO research guidelines are appropriate. 
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ARTICLE 8 Availability of plant material 
Relevant government agencies will be informed of any networking involving bilateral agreements 
where research and materials are to be conducted and made available across national bounda- 
ries. Access to materials will be on mutuafly agreed terms in accordance with Article 15 of the 
Convention on Biological Diversity. 
In the event that international concens express interest in bio-active agents identified during net- 
work research, equitable partnerships will be developed to accord with any relevant national law 
and the Convention on Biological Diversity so that positive inputs in economic terms can be made 
to conservation and the establishment of local production of herbal medicines. 
ARTICLE 9 Indigenous knowledge 
The network recognizes that traditional use of a herbal medicine is usually a part of culture. Folk- 
lore and traditional knowledge should therefore be an integral part of research planning, and such 
knowledge should be respected, acknowledged and interpreted during the development of research 
proposals. Communities which provide such knowledge should be involved with research objec- 
tives, research planning, and be informed of the results generated. 
ARTICLE 10 Sustainability of plant resources 
Where collecting plant material results in destruction of the plants, guidelines need to be developed 
to assure regeneration. 
Where plant resources are rare in nature, and over-exploited in specific areas, or otherwise under- 
going genetic erosion or population fragmentation from any cause, the network will pursue re- 
search to bring suitable genotypes into cultivation to provide reliable and sustainable sources of 
material. 
This Article accords with Article 10 of the Convention of Biological Diversity and Chapters 15 and 
32 of Agenda 21. 
ARTICLE 11 Other ethical considerations 
A number of other ethical considerations impinge on research. The network recognizes the follow- 
ing principles: 
(i) Research planning has to differentiate between herbal medicines which have a well-docu- 
mented background resulting from long usage and those where traditional usage is unclear 
and not well-documented. 
In this respect, questions of safety and efficacy arise. Plants which are both effective and non- 
toxic in a particular treatment can be promoted for wider use for that treatment, but, promotion 
of those which are toxic is unethical as currently used. 
(ii) The promotion of plants which are sanctioned as non-toxic but lack sanctioning as effective 
may occur where significant numbers of people exist who can have access to such plants but 
lack alternative treatments, documented and known to be effective 
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(iii) Plant remedies not sanctioned to be non-toxic will not be promoted. However, research can 
be pursued on them with a view to identifying safe limits. This principle can be applied to 
diverse sources of the same species which vary in their active principle contents, and where 
use in therapy can be queried on safety grounds. 
(iv) Provided that no plants are known or suspected to be toxic, the promotion of multiple plant 
preparations-where one or more is not sanctioned as non-toxic- - is ethical only in situations 
where reasonable and known-to-be-safe alternatives do not exist, and where research is 
underway to determine the safety of the non-sanctioned plant. 
(v) Where research involves human beings it will be conducted in accordance with principles of 
respect for persons, justice, benefit, and lack of maleficence. 
(vi) Promotion of any herbal remedy through the network will accord with required regulatory mecha- 
nisms in the country and will only be deemed permissible if concepts of equity and sustainable 
development are taken into account. 
WHO International Symposium on Medicinal Plants held at the Morris Arboretum, PA, USA 19- 
21, April, 1993. 
Proceedings of an International Workshop, IDRC, Ottawa, Canada, 2-4 March, 1994. 
WHO Research Guidelines for Evaluating the Safety and Efficacy of Herbal Medicines, 1993. 





From 15-17 May 1996, a workshop was held in Pokhara, Nepal, hosted by the Institute of For- 
estry, Tribhuvan University, Pokhara. The workshop was conducted under the auspices of the 
International Centre for Integrated Mountain Development (ICIMOD); the International Develop- 
ment Research Centre (IDRC); the IDRC Medicinal Plants Network (IMPN); the International 
Network for Bamboo and Rattan (INBAR) and the International Plant Genetic Resources Institute 
(IPGRI). It was attended by delegates from the six countries of the Himalayan Region and beyond, 
including Pakistan, India, Nepal, Bangladesh, China and Thailand, whose fields of expertise in- 
cluded areas such as economics and management of forest and agricultural resources; Indig- 
enous peoples and cultural traditions and mountain development. Ways and means of developing 
specific non-timber forest resources in a more sustainable manner than hitherto carried out were 
discussed, and the conclusions reached were formulated into what has become known as the 
Pokhara Declaration. 
The delegates agreed on the following declaration: 
WE RECOGNISE THAT THE FOLLOWING FACTORS ARE OF CRITICAL CONCERN: 
1. Over 120 million people in the Himalayan region rely on plant products, mostly extracted from 
the wild, and over 450 million people have interlinkages with this economy downstream. 
2. Non-timber forest resources, including bamboo, rattan, and medicinal plants, play a vital role 
in this region. They are invaluable to the livelihoods and cultural traditions of its richly diverse 
human communities. 
3. The region which is ecologically complex, diverse, and fragile, is heavily degraded and rapidly 
becoming impoverished in terms of biological diversity. 
4. Many existing production systems are equally fragile and threatened, resulting in grave threats 
to the livelihoods of millions of disadvantaged people. 
5. Degradation is directly related to factors including increasing populations; indiscriminate ex- 
traction harvesting; overgrazing; soil erosion; open cast mining; shifting cultivation and other 
changing patterns of land use. 
WE ALSO TAKE NOTE OF A NUMBER OF ISSUES CONCERNING KNOWLEDGE: 
1. There is a wide gap in knowledge regarding collection and utilization of bamboo, rattan, and 
medicinal plants in the region, and research capabilities and interests vary widely between the 
different countries of the region. 
2. Where information does exist, it is inadequate, uncritical, and often not easily accessible to 
researchers, farming communities, governments, and development agencies, resulting in many 
inadequate or restrictive policies and regulations. 
57 
Priorities for Medicinal Plants Research and Development in Pakistan 
3. There is a lack of information about the demand and supply situation; market intelligence, and 
the actual operation of local, national, regional and international trade of these commodities. 
4. There is a lack of attention to the development of appropriate technologies and extension which 
will enhance, on the one hand, the sustainable production systems of the poor and, on the 
other, conserve the resource base, protect essential watersheds, and reduce soil erosion. 
THE WORKSHOP PARTICIPANTS AGREED UPON HE FOLLOWNG RESOLUflON. 
1. There is an urgent need to conduct integrated, innovative, and collaborative research to obtain 
the information required to solve the constraints and problems noted above. 
2. There is an urgent need to seek peoples' participation at the grassroots community level, 
thereby making them full partners in the research. 
3. Such research should be strategically focused to improve conservation, cultivation, produc- 
tion, sustainable management, and utilization of a limited number of priority species initially. 
4. There is an urgent need for interdisciplinary cooperation, networking, and information dissemi- 
nation in the region. 
5. The results of such research should have measurable and sustainable beneficial impacts on 







































Through support for research, 
Canada's International Develop- 
ment Research Centre (IDRC) 
assists scientists in developing 
countries to identif long-term, 
workable solutions to pressing de- 
velopment problems. Support is 
given directly to scientists working 
in universities, private enterprise, 
government, and nonprofit organi- 
zations. 
Priority is given to research aimed 
at achieving equitable and sus- 
tainable development worldwide. 
Projects are designed to maximize 
the use of local materials and to 
strengthen human and institu- 
tional capacity. 
Led by the dedication and innova- 
tive approach of Third World sci- 
entists — often in collaboration 
with Canadian partners — IDRC- 
supported research is using science 
and technology to respond to a wide 
range of complex issues in the de- 
veloping world. 
IDRC is directed by an international 
Board of Governors and is funded 
by the Government of Canada. At 
the United Nations Conference 
on Environment and Development 
(UNCED), IDRC's mandate was 
broadened to emphasize sustain- 
able development issues. IDRC's 
international network and exper- 
tise will be used to help the world 
move toward implemenlation of 
UNCED's Agenda 21 program of 
action. 
Le Centre de recherches pour le 
développement international (CR1)!) 
soutient des travaux et des activi- 
tés de recherche dans les pays en 
développement de manière a as- 
surer un developpement durable et equitable a l'échelle mondiale. 
Les recherches sont menées par 
des scientifiques affiliés a des insti- 
tutions, a des entreprises, a des 
gouvemements ou a des organismes 
de développement. Des partenaires 
canadiens y contribuent regulière- 
ment. 
Les projets soutenus financièrement 
ou techniquement par le CRDI 
privilégient le recours aux ressources 
locales et s'appuient sur le genie, 
l'intelligence et le sens de l'inno- 
vation des chercheurs des pays en 
développement. 
Le CR1111 contribue au renforcement 
des connaissances et des capacites 
de recherche des pays en développe- 
ment pour lutter contre Ia pauvrete 
et pour améliorer les conditions 
de vie et l'environnement des 
populations affectées. 
Le CRDI est dirige par un Conseil 
des gouverneurs international. Ses 
fonds proviennent du gouverne- 
ment du Canada. La Conference 
des Nations unies sur l'environ- 
nement et le développement 
(CNUED) a choisi le CRDI pour 
participer a la mise en oeuvre du 
développement durable a l'échelle 
planétaire. Le CRDI verra a con- 





de el Desar 
rob (CuD) financIa trabajos y ac- 
tividades de investigación en los 
paIses en desarrollo. Las investi- 
gaciones están a cargo de cientIfi- 
cos que trabajan en instituciones, 
empresas, gobiernos u organismos 
dedicados al desarrollo. Estos cientI- 
ficos reciben regularmente la co- 
laboración de sus colegas 
canadienses. 
Los proyectos apoyados financiera 
o técnicamente por el CuD favore 
cen el uso de recursos locales y se 
apoyan en el talento, la inteligen- 
cia y el sentido de innovación de 
los investigadores de los paIses en 
desarrollo. 
El CuD contribuye al fortalecimiento 
de los conocimientos y a la capaci- 
dad investigativa de los paIses en 
desarrollo para luchar contra la 
pobreza y mejorar las condiciones 
de vida y el medio ambiente de las 
poblaciones afectadas. 
Un Consejo de Gobernadores In- 
ternacional tiene a su cargo la di- 
rección del CuD, cuyos fondos 
provienen del Gobierno de Canada. 
La Conferencia de Naciones Unidas 
sobre el Medio Ambiente y el De- 
sarrollo (CNUED) ha selecciona- 
do al CuD para participar en la 
realización del desarrollo sostenible 
a escala mundial. El CuD se en- 
cargará de hacer realidad el pro- 
grama Agenda 21, elaborado 
durante la Cumbre de la Tierra. 
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